We pride ourselves in providing best-in-class products coupled with expert technical and logistical support to bring superior working solutions to a wide range of clinical testing workflows and operations. We use our decades of experience in PCR, RT-PCR, and NGS to match your requirements for each unique clinical and diagnostic application.
Learn more about some of the featured molecular diagnostic applications we have supported, and contact us to find out how we can help.
When the conventional RNA extraction approach wasn't cutting it—lengthening turnaround time and limiting the capacity of COVID-19 testing at Indiana Regional Medical Center—Dr. Bharathan, chair of the Department of Biology at IUP, and his lab stepped up to develop a fast, sensitive extractionless protocol using Takara Bio's PrimeDirect Probe mix.
Innovative COVID-19 testing solutions
Rapid, reliable, large-scale detection of SARS-CoV-2 is crucial for controlling the COVID‑19 pandemic. An effective SARS-CoV-2 detection method must be able to detect just a few copies of the virus using a streamlined protocol that simplifies sample preparation and handling to reduce the risk of contamination. Explore how our solutions were implemented by testing labs for SARS-CoV-2 assays.
Push the boundaries
High-throughput antibiotic resistance surveillance
There are currently over 1,000 types of antibiotic resistance genes (ARGs) that have been identified to confer resistance to the hundreds of available antibiotics. Consequently, monitoring human and environmental samples for ARGs requires the ability to perform high-throughput (HTP) real-time PCR screens for many different target sequences in numerous sample types. Explore our advanced solutions for antibiotic-resistance surveillance.
Get the HTP advantage
High-throughput pathogen detection
Specialized RT-qPCR- and PCR-based detection methods have been developed for respiratory viruses such as SARS-CoV-2, antibiotic-resistant and disease-causing bacteria, and other pathogens affecting human health. High-throughput detection methods that deliver precision, reproducibility, and speed make it possible to perform the large-scale screening required to track and control disease outbreaks.
Screen with confidenceTakara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
©2024 Takara Bio Inc. All Rights Reserved.
Region - North America Privacy Policy Terms and Conditions Terms of Use
Overcoming roadblocks in the test development process to improve rural hospital COVID-19 testing (5 min)
When the conventional RNA extraction approach wasn't cutting it—lengthening turnaround time and limiting the capacity of COVID-19 testing at Indiana Regional Medical Center—Dr. Bharathan, chair of the Department of Biology at IUP, and his lab stepped up to develop a fast, sensitive extractionless protocol using Takara Bio's PrimeDirect Probe mix.